The Latest Breaking News from William Blair

Analysts Are Feeling Bullish on CoreWeave Stock. Here's Why.

CoreWeave shares inch higher on a bullish William Blair research note. Here’s why the investment firm recommends owning CRWV stock.

Barchart · Sep 30

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

As per a media report over the weekend, AstraZeneca Plc (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY) are in potential discussions to form a pharmaceutical giant valued at nearly $400 billion.

Benzinga · Aug 3

SpaceX stock falls back to earth shortly after Wall Street analysts release florid targets: 'Paving the superhighway to the stars'

A wave of wildly bullish price targets from Wall Street's SpaceX underwriters arrived just before the stock fell—raising questions about how much analysts really know.

Fortune · Jul 18

Old tech can learn new tricks. Colorful comparison photos of Crab Nebula wouldn’t have been possible with newer telescopes, NASA says

Images of the same colorful nebulae 25 years apart are a key example of why the Hubble Space Telescope's longevity matters

Digital Camera World · Mar 23

Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) on Monday presented updated and expanded data from the ongoing CARDINAL trial of TERN-701 in previously treated chronic myeloid leukemia (CML) patients at the American Society of Hematology Annual Meeting and Exposition.

Benzinga · Dec 9, 2025

Ocular Therapeutix Stock Skyrockets On Faster FDA Path For Vision Drug

Ocular Therapeutix Inc. (NASDAQ:OCUL) stock surged on Monday after the company announced plans to accelerate the timeline for submitting a New Drug Application (NDA) for Axpaxli (OTX-TKI) in the treatment of wet age-related macular degeneration (wet AMD).

Benzinga · Dec 8, 2025

Medtronic Scores FDA Win As Hugo Surgical Robot Enters 230,000 Urology Procedure Market

On Wednesday, the U.S. Food and Drug Administration (FDA) cleared Medtronic Plc’s (NYSE:MDT) Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures.

Benzinga · Dec 4, 2025

Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound

Simulations Plus Inc. (NASDAQ:SLP) shares climbed on Tuesday after the company reported better-than-expected fourth-quarter 2025 earnings and reaffirmed annual guidance.

Benzinga · Dec 2, 2025

Janux Therapeutics Stock Hits 52-Week Low After Trial Update

Janux Therapeutics Inc. (NASDAQ:JANX) stock hit a 52-week low on Tuesday after the company released updated interim data for its JANX007 Phase 1 program for metastatic castration-resistant prostate cancer (mCRPC).

Benzinga · Dec 2, 2025

Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study

Bayer AG (OTC:BAYRY) released topline results from the Phase 3 OCEANIC-STROKE study, with its investigational, once daily, oral FXIa inhibitor asundexian.

Benzinga · Nov 24, 2025